By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Endonovo Therapeutics 

Los Angeles   California    U.S.A.
Phone: n/a Fax: n/a



Company News
Endonovo Buys Back Convertible Note From Lender Avoiding Any Immediate Dilution 12/14/2015 1:36:24 PM
Endonovo Developing Next-Generation Cell Therapy For Acute and Chronic Graft-Versus-Host Disease Using Cell-Enhancing Cytotronics Platform 11/3/2015 10:54:48 AM
Endonovo Files Patent Application on Cell Therapy Created Using Its Proprietary Cell-Enhancing Cytotronics Platform 10/27/2015 9:27:07 AM
Endonovo Therapeutics Announces Immunotronic And Cytotronic Platforms 10/7/2015 1:19:22 PM
Endonovo Therapeutics Announces Method For Large Scale Expansion Of Cord Blood 10/2/2015 11:07:56 AM
Endonovo Therapeutics Announces Corporate Patent Licensing Program 9/18/2015 11:26:43 AM
Endonovo Therapeutics Targets Non-Invasive Treatment For Acute And Chronic Inflammatory Conditions Of The Liver 4/8/2015 11:38:50 AM
Endonovo Therapeutics Enters Into A $3 Million Equity Purchase Agreement With Kodiak Capital Group, LLC 1/21/2015 8:02:21 AM
Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA Regulatory Pathway For Urinary Incontinence Treatment 12/4/2014 3:15:22 PM
Endonovo Therapeutics Files Patent On Bioelectronic Technology, Devices And Therapies 9/2/2014 12:15:51 PM